These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3965948)

  • 1. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
    Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
    N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth disorders in childhood].
    Bierich JR
    Fortschr Med; 1972 Sep; 90(27):961-6. PubMed ID: 4653170
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal growth hormone and dwarfism.
    Abucham-Filho JZ; Czepielewski MA; Ribeiro SR; Jaber HE; Lengyel AM; Chacra AR; Vieira JG
    N Engl J Med; 1985 Jul; 313(4):268-9. PubMed ID: 4040212
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human somatomedin. Determination, occurrence, biological activity and purification.
    Hall K
    Acta Endocrinol Suppl (Copenh); 1972; 163():1052. PubMed ID: 4538721
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].
    Isidori A; Cianfriglia F; Dondero F
    Folia Endocrinol; 1974 Apr; 27(2):179-84. PubMed ID: 4406489
    [No Abstract]   [Full Text] [Related]  

  • 10. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with human growth hormone in hereditary idiopathic pan-hypophysiotropic dwarfism. Research and quantitative estimation of antibodies].
    Assis LM; Toledo SP; Schwarz I; Bartolini P; Mattar E; Pieroni RR
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):24-32. PubMed ID: 663508
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children: normal children and HGH-treated pituitary dwarfs.
    Garnier PE; Job JC
    Acta Endocrinol (Copenh); 1977 Sep; 86(1):50-9. PubMed ID: 578613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism.
    Grunt JA; Enriquez AR; Daughaday WH
    J Clin Endocrinol Metab; 1972 Jul; 35(1):157-68. PubMed ID: 5032510
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of endocrine diseases in childhood and adolescence. 4: Hypophyseal dwarfism].
    Butenandt O
    Fortschr Med; 1984 Sep; 102(34):838-40. PubMed ID: 6436153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
    Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA
    J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of hGH treatment on somatomedin levels in the serum (as determined by 35-S uptake into cartilage).
    Schimpff RM; Donnadieu M; Gourmelen M; Girard F
    Horm Metab Res; 1974 Nov; 6(6):494-8. PubMed ID: 4476721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of hypopituitary dwarfism (author's transl)].
    Schönberg D
    Monatsschr Kinderheilkd (1902); 1973 Oct; 121(10):652-5. PubMed ID: 4589192
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Hall K; Olin P
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):417-33. PubMed ID: 5067009
    [No Abstract]   [Full Text] [Related]  

  • 19. Fractionation studies on plasma of normals and patients with Laron dwarfism and hypopituitary gigantism.
    Bala RM; Beck JC
    Can J Physiol Pharmacol; 1973 Nov; 51(11):845-32. PubMed ID: 4762432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of radioimmunological determination of the somatotropic hormone in a series of children with low body height for the diagnosis of pituitary dwarfism].
    Lostia O; Boscherini B; Finocchi G; Girotti F; Mancuso G; Sartori L; Rossi C
    Ann Ist Super Sanita; 1971; 7(2):440-4. PubMed ID: 5154668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.